NIH-funded research R21 grant

3D cellular imaging of medical tracers in tissues

Official title: Three-dimensional imaging of radiopharmaceutical distribution in multicellular organism at cellular resolution

Funded at University of Wisconsin Milwaukee · NIH-11285151 · Data updated 2026-11-12

This project builds a tiny 3D microscope to show how medical imaging tracers and radiopharmaceuticals move through patient-derived tissue samples to help people who get PET scans or radiotracer treatments.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionUniversity of Wisconsin Milwaukee
NIH-funded
Lab location1 site (Milwaukee, United States)
Project startMarch 15, 2024
Project endFebruary 28, 2027
Funding year2026
Award (this year)$119,607
NIH project number5R21EB035205-03
Project IDNIH-11285151 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates to contribute would be patients able to donate tumor or other tissue samples (for example during biopsy or surgery) whose samples could be made into organoids for tracer testing.

Less likely to help

People seeking immediate medical treatment outcomes, healthy volunteers without tissue to donate, or those unwilling to provide samples are unlikely to receive direct benefit from participating.

What this research studies

Researchers will build a new microscopic nuclear imaging device based on radioluminescence microscopy to record where clinical tracers go inside thick, living multi-cellular samples. The team will image patient-derived organoids and other intact tissue samples to map tracer distribution at cellular resolution in three dimensions. By comparing these high-resolution maps to existing PET and autoradiography data, they aim to improve how clinical nuclear images are interpreted and to test candidate radiopharmaceuticals before patient use. Work is primarily laboratory-based and focused on imaging methods rather than treating patients directly.

Why it matters

Potential benefit: If successful, this could help doctors read PET scans more accurately and guide selection of safer, more effective radiopharmaceuticals for patients.

How similar studies have gone: This builds on existing methods like microautoradiography and radioluminescence microscopy but is a novel effort to achieve high-resolution 3D imaging in thick, living tissue and patient-derived organoids.

Where this research is happening

  • University of Wisconsin Milwaukee
    Milwaukee, United States
    Active

Researchers

  • Principal investigator: Sung, Yongjin — University of Wisconsin Milwaukee
  • Study coordinator: Sung, Yongjin

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.